Patients who experience sudden vision changes while taking Ozempic are urged to seek immediate medical attention
The most common examples are: Semaglutide (brand name Wegovy) Tirzepatide (brand name Mounjaro) Liraglutide (brand names Saxenda or Victoza) These medicines have shown significant results in clinical studies, with many patients achieving meaningful weight loss when treatment is combined with lifestyle changes
Do not stop tirzepatide without medical guidance, particularly if you're taking it for diabetes management
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
You can find her book Best Fork Forward on Amazon with: 60 high-protein, quick recipes designed for bariatric patients that apply directly to GLP-1 patients